Protein A 40nm OD10 100ml

Added to your cart

Protein A 40nm OD10 100ml

Cart subtotal: £0.00

View cart (0) Checkout

#SKU BA.PAG40/7

£1911.00

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

Protein A if part of the anti-human conjugate family and consists of Protein A conjugated to BBI 40nm citrate capped gold nanoparticles. This Protein A is a native secreted form produced in Staphylococcus aureus and affinity purified. Its form is a single polypeptide chain of MW 42.0 kDa. It has two accessible high affinity binding sites for the Fc region of IgG and secondary binding sites for the Fab region which enables binding to a wide spectrum of antibodies and their subclasses from different species. The conjugate is suspended in a low molarity buffer 2mM disodium tetraborate buffer, pH7.2, containing 0.095% Sodium Azide as preservative. This buffer will maintain the activity of the antibody attached to the surface of the gold colloid, without causing particle aggregation, and can easily be substituted for a customers buffer of choice for their assay. This product can be purchased online in 5ml volumes at OD10. For larger volumes, please discuss your requirements with our sales team.
100ml
BA.PAG40/7

More information

Attributes

Description

  • Shipping Information
  • If you are based outside of the EU there will be a 5 day lead time added to your order to enable us to comply with the Animal and Plant Health Agency (APHA) export/import policy
  • Specification
  • OD10, Mean Particle Diameter 37 - 43nm, % CV≤ 8.0%
  • Recommended Use
  • Lateral Flow
  • Preservatives
  • 0.095% azide
  • Lead Time
  • 2 weeks
  • Buffer
  • Low molarity Borax buffer
  • Optical Density
  • OD10
  • Particle Size
  • 40nm

Technical Documents

Safety Data Sheet (82.52KB)

Product Information (384.96KB)

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox